ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 337

$577K Total Retail Price of All Prescriptions

Rank: 51 out of 337

429 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 10,960 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 643 567 1 1
AMLODIPINE BESYLATE 586 526 2 3
OMEPRAZOLE 574 453 3 4
LISINOPRIL 463 406 4 2
LEVOTHYROXINE SODIUM 404 376 5 5
HYDROCODONE-ACETAMINOPHEN 327 206 S3 6 13
SERTRALINE HCL 325 267 7 18
FLUTICASONE PROPIONATE 304 269 8 34
ATENOLOL 304 280 8 10
FUROSEMIDE 295 271 10 8
CITALOPRAM HBR 289 231 11 17
LOSARTAN POTASSIUM 280 247 12 15
ALENDRONATE SODIUM 272 247 13 19
METOPROLOL TARTRATE 271 238 14 6
METOPROLOL SUCCINATE 263 224 15 21
HYDROCHLOROTHIAZIDE 259 247 16 9
METFORMIN HCL 223 173 17 12
ATORVASTATIN CALCIUM 212 192 18 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 129 19 31
SYNTHROID 155 117 20 41
ZOLPIDEM TARTRATE 143 119 21 23
PRAVASTATIN SODIUM 137 111 22 14
LOSARTAN-HYDROCHLOROTHIAZIDE 133 133 23 60
CEFUROXIME 132 118 24 167
LOVASTATIN 126 119 25 24
DIOVAN 124 110 26 26
EVISTA 118 118 27 102
GLIMEPIRIDE 117 110 28 55
WARFARIN SODIUM 113 113 29 11
METFORMIN HCL ER 106 82 30 52
PANTOPRAZOLE SODIUM 104 74 31 36
PAROXETINE HCL 95 95 32 46
OXYBUTYNIN CHLORIDE 93 59 33 143
FINASTERIDE 91 81 34 83
GABAPENTIN 88 74 35 20
CIPROFLOXACIN HCL 84 73 36 71
ALLOPURINOL 84 82 36 28
TAMSULOSIN HCL 84 80 36 25
POLYETHYLENE GLYCOL 3350 83 31 39 47
ALPRAZOLAM 83 76 39 78
RANITIDINE HCL 83 57 39 30
LIPITOR 82 76 42 33
MELOXICAM 79 71 43 54
DIOVAN HCT 77 77 44 88
CLOPIDOGREL 72 61 45 42
GLYBURIDE 72 72 R 45 53
TRAZODONE HCL 67 51 47 16
CRESTOR 66 44 48 29
ZETIA 66 54 48 89
CYCLOBENZAPRINE HCL 66 18 R 48 103
POTASSIUM CHLORIDE 65 54 51 62
ONGLYZA 64 57 52 244
ROPINIROLE HCL 63 57 53 141
PROPRANOLOL HCL 62 45 54 121
NEXIUM 57 27 55 56
CARVEDILOL 56 44 56 73
AMITRIPTYLINE HCL 54 54 R 57 75
PREDNISONE 53 41 58 40
KLOR-CON M20 52 51 59 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.